LMR Partners’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

LMR Partners’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-175,000	Closed	-$3.27M	–	1561
2022 Q1	$3.27M	Hold	175,000	–	–	0.04%	416
2021 Q4	$3.74M	Buy	+175,000	New	+$3.45M	0.04%	303

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

LMR Partners's OCDX Position: Q2 2022 in Review

LMR Partners sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 175,000 shares — an estimated $3.27M sold.

LMR Partners first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $3.74M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

LMR Partners reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
LMR Partners sold 175,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $3.27M.
LMR Partners first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
LMR Partners's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.74M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.